Resources

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

As the New Year 2022 begins, a lot of compliance professionals might also be making new year resolutions about being more diligent with their monitoring. Here’s a quick recap of the PhRMA Code that recently got updated in the wake of OIG’s Special Fraud Alert for Speaker Programs. The Seven Principles of Speaker Programs The […]

qordata hosted a webinar with Seth Lundy and Brian Bohnenkamp from King & Spalding to keep the compliance community updated with recent changes in PhRMA Code and the implications on life sciences compliance after those revisions. A number of questions were raised in our webinar that Seth and Brian tried to answer. Here’s a summary […]

On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released highly anticipated revisions to its Code on Interactions with Health Care Professionals, effective January 1, 2022.  In order to keep our compliance community updated with these changes, qordata collaborated with Seth Lundy and Brian Bohnenkamp from King & Spalding to bring forth […]

AUGUST 17th, NEW JERSEY: New Jersey-based compliance solutions and IT consulting services provider qordata has made it to Inc. 5000’s 2021 list as one of the fastest-growing private companies in the US. As the Inc. 5000 formally announced this year’s list, qordata has achieved the 1351st spot. The Inc. 5000 lists the 5,000 fastest-growing private […]

The Open Payments program is a transparency program that provides clarity between Pharmaceutical Manufacturers and the payments they make to healthcare providers and teaching hospitals. As  Pharmaceutical Manufacturers, Open Payments require you to report all direct and indirect payments or transfers of values made to physicians, teaching hospitals, and basically anyone in the healthcare sector […]

In November 2020, The United States Department of Health and Human Services Office of Inspector General (OIG) issued a “Special Fraud Alert: Speaker Programs“. The Special Fraud Alert highlights the fraud and abuse risks associated with the offer, payment, solicitation, or receipt of remuneration relating to speaker programs by life sciences companies. It raises questions […]